CastleKnight Management’s HCA Healthcare HCA Stock Holding History

CastleKnight Management’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,150	Closed	-$579K	–	234
2022 Q3	$579K	Sell	3,150 -390	-11%	-$77.7K	0.08%	129
2022 Q2	$595K	Buy	+3,540	New	+$761K	0.1%	135

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CastleKnight Management's HCA Position: Q4 2022 in Review

CastleKnight Management sold out of HCA Healthcare (HCA) in Q4 2022, closing a stake of 3,150 shares — an estimated $579K sold.

CastleKnight Management first reported a position in HCA in Q2 2022 and held it in 2 quarters. The position peaked at $595K in Q2 2022. 962 funds tracked by Wall St. Rank hold HCA as of Q4 2022.

CastleKnight Management reported no remaining HCA Healthcare position as of Q4 2022 after selling out during the quarter.
CastleKnight Management sold 3,150 HCA Healthcare shares in Q4 2022, an estimated $579K.
CastleKnight Management first reported a position in HCA Healthcare in Q2 2022 and held it in 2 quarters.
CastleKnight Management's HCA Healthcare position peaked at $595K in Q2 2022.
962 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2022.

Based on CastleKnight Management's 13F filing for Q4 2022, filed 14 Feb 2023.